|
|
J Neurol Neurosurg Psychiatry. 1993 March; 56(3): 268–273. | PMCID: PMC1014859 |
Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease. D Caparros-Lefebvre, S Blond, P Vermersch, N Pécheux, J D Guieu, and H Petit Department of Neurology, CHRU Lille, France. Abstract Chronic thalamic stimulation was performed in 10 Parkinsonian patients with disabling tremor and poor response to drug therapy. During the stereotactic procedure, an electrode was introduced in the ventralis intermediate nucleus of the thalamus. Test stimulation was performed during the intra-operative procedure and a few days after surgery using an external stimulator. When tremor was obviously reduced by thalamic stimulation, an internal stimulator was implanted under the clavicle. Tremor was initially suppressed in all cases and reappeared whenever stimulation was stopped. Patients were followed for 22 to 34 months. Tremor was controlled in eight cases but reappeared after three months in two cases. Levodopa induced dyskinesias were observed before electrode implantation in 5 cases. They consisted of peak-dose choreic or ballistic dyskinesias in 4 cases and biphasic dystonic dyskinesias in 3 cases. Peak-dose dyskinesias were greatly improved or suppressed in all cases. Biphasic dyskinesias were improved in 2 cases. Thalamic stimulation was well tolerated. Mild dystonic hand posture related to the deep brain stimulation was observed in one case. No neuropsychological side-effects were noted. Thalamic stimulation could prove to be an adequate treatment for resistant tremor and levodopa induced dyskinesias. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. These references are in PubMed. This may not be the complete list of references from this article. - Ohye C, Narabayashi H. Physiological study of presumed ventralis intermedius neurons in the human thalamus. J Neurosurg. 1979 Mar;50(3):290–297. [PubMed]
- Hirai T, Miyazaki M, Nakajima H, Shibazaki T, Ohye C. The correlation between tremor characteristics and the predicted volume of effective lesions in stereotaxic nucleus ventralis intermedius thalamotomy. Brain. 1983 Dec;106 (:1001–1018. [PubMed]
- Tasker RR, Siqueira J, Hawrylyshyn P, Organ LW. What happened to VIM thalamotomy for Parkinson's disease? Appl Neurophysiol. 1983;46(1-4):68–83. [PubMed]
- Wester K, Hauglie-Hanssen E. Stereotaxic thalamotomy--experiences from the levodopa era. J Neurol Neurosurg Psychiatry. 1990 May;53(5):427–430. [PubMed]
- Blond S, Siegfried J. Thalamic stimulation for the treatment of tremor and other movement disorders. Acta Neurochir Suppl (Wien). 1991;52:109–111. [PubMed]
- Brice J, McLellan L. Suppression of intention tremor by contingent deep-brain stimulation. Lancet. 1980 Jun 7;1(8180):1221–1222. [PubMed]
- Andy OJ. Thalamic stimulation for control of movement disorders. Appl Neurophysiol. 1983;46(1-4):107–111. [PubMed]
- Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol. 1987;50(1-6):344–346. [PubMed]
- Benabid AL, Pollak P, Hommel M, Gaio JM, de Rougemont J, Perret J. Traitement du tremblement parkinsonien par stimulation chronique du noyau ventral intermédaire du thalamus. Rev Neurol (Paris). 1989;145(4):320–323. [PubMed]
- Benabid AL, Pollak P, Gervason C, Hoffmann D, Gao DM, Hommel M, Perret JE, de Rougemont J. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet. 1991 Feb 16;337(8738):403–406. [PubMed]
- Caparros-Lefebvre D, Blond S, Pécheux N, Pasquier F, Petit H. Evaluation neuropsychologique avant et après stimulation thalamique chez 9 parkinsoniens. Rev Neurol (Paris). 1992;148(2):117–122. [PubMed]
- Narabayashi H. Lessons from stereotaxic surgery using microelectrode techniques in understanding parkinsonism. Mt Sinai J Med. 1988 Jan;55(1):50–57. [PubMed]
- Cooper IS. Neurosurgical treatment of the dyskinesias. Clin Neurosurg. 1977;24:367–390. [PubMed]
- Hughes RC, Polgar JG, Weightman D, Walton JN. L-dopa in Parkinsonism and the influence of previous thalamotomy. Br Med J. 1971 Jan 2;1(5739):7–13. [PubMed]
- Narabayashi H, Yokochi F, Nakajima Y. Levodopa-induced dyskinesia and thalamotomy. J Neurol Neurosurg Psychiatry. 1984 Aug;47(8):831–839. [PubMed]
- Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989 Oct;12(10):366–375. [PubMed]
- Boyce S, Clarke CE, Luquin R, Peggs D, Robertson RG, Mitchell IJ, Sambrook MA, Crossman AR. Induction of chorea and dystonia in parkinsonian primates. Mov Disord. 1990;5(1):3–7. [PubMed]
- Crossman AR. A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment. Mov Disord. 1990;5(2):100–108. [PubMed]
- Crossman AR, Mitchell IJ, Sambrook MA, Jackson A. Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex. The site of drug action and a hypothesis for the neural mechanisms of chorea. Brain. 1988 Oct;111(Pt 5):1211–1233. [PubMed]
- Mitchell IJ, Cross AJ, Sambrook MA, Crossman AR. Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced parkinsonism in the monkey: relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptake. Neurosci Lett. 1986 Jan 2;63(1):61–65. [PubMed]
- Graybiel AM, Ragsdale CW., Jr Fiber connections of the basal ganglia. Prog Brain Res. 1979;51:237–283. [PubMed]
- Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986;9:357–381. [PubMed]
|
This article has been